Bellicum Pharmaceuticals Company
Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).
Technology:
CAR-T therapy, Cell-based gene therapy, Сancer Diagnostics
Industry:
Genomic and Epigenominc Instabillity, Public
Headquarters:
Houston, Texas, United States
Founded Date:
2004-07-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
15
Total Funding:
289575000
Estimated Revenue:
Less than $1M
Last Funding Date:
2020-10-29
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership